Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Inventory (2020 - 2025)

Oncology Institute's Inventory history spans 6 years, with the latest figure at $16.9 million for Q4 2025.

  • For Q4 2025, Inventory rose 68.09% year-over-year to $16.9 million; the TTM value through Dec 2025 reached $16.9 million, up 68.09%, while the annual FY2025 figure was $16.9 million, 68.09% up from the prior year.
  • Inventory reached $16.9 million in Q4 2025 per TOI's latest filing, down from $18.9 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $18.9 million in Q3 2025 to a low of $6.4 million in Q4 2021.
  • Average Inventory over 5 years is $11.6 million, with a median of $11.3 million recorded in 2024.
  • Peak YoY movement for Inventory: decreased 26.6% in 2024, then surged 86.84% in 2025.
  • A 5-year view of Inventory shows it stood at $6.4 million in 2021, then soared by 43.85% to $9.3 million in 2022, then surged by 47.69% to $13.7 million in 2023, then decreased by 26.6% to $10.0 million in 2024, then surged by 68.09% to $16.9 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Inventory are $16.9 million (Q4 2025), $18.9 million (Q3 2025), and $15.8 million (Q2 2025).